Healthcare News and Headlines
Healthcare News and Headlines
The FDA convened a meeting with several states, Indian tribes and federal partners to discuss the Section 804 importation program, which permits importing prescription drugs from Canada to lower U.S. prices. The agency highlighted its pre‑review process, cost‑savings analysis support, and a newly launched quality‑assurance tool to help sponsors craft compliant proposals. This effort advances President Trump’s executive order aimed at reducing prescription drug costs while maintaining safety standards. Presentations from the meeting are publicly available on the FDA website.
Researchers at Boston University successfully removed a caudate lobe liver metastasis from a 79‑year‑old using a surgical robot. The team combined a hanging maneuver on the Arantius ligament with indocyanine green negative staining to delineate tumor margins. Intra‑operative ultrasound guided...
Heart to Heart Hospice announced the opening of two de novo locations in Huntsville and Hemphill, Texas, extending its footprint to nine additional counties. The expansion brings the provider’s total network to 67 sites across Indiana, Michigan, Oklahoma, and Texas....
Pediatric respite care, vital for families of seriously ill children, has long faced limited reimbursement and unclear licensing. Over the past four years, the number of programs grew from 23 to 48, with 25 new or developing sites across 28...
A Finnish observational study of 78 advanced heart‑failure patients found that 24‑month survival and costs are comparable for elective left ventricular assist device (LVAD) implantation and heart transplantation. In contrast, urgent LVAD placement after ECMO support resulted in markedly lower...
Oracle Health will showcase a suite of AI‑driven solutions at HIMSS26, including its Clinical AI Agent that has been adopted by more than 300 organizations and has saved doctors over 200,000 hours of documentation time. The company is also unveiling...
Sanford Health, the nation’s largest rural provider serving over two million patients across seven states, leveraged a $350 million donation to accelerate its virtual‑care program. The organization opened a Sioux Falls virtual‑care center that educates clinicians on digital bedside manner and hosts an...
A recent Annenberg Public Policy Center poll reveals that career scientists and independent experts enjoy higher public trust than leaders of the U.S. Department of Health and Human Services (HHS). Trust in federal public‑health agencies has declined steadily since the...
DigitalHealth.London’s latest guide walks innovators through translating a UK NHS digital health case study into a compelling story for the Danish market. It outlines key regulatory, data‑privacy, and reimbursement differences between the two systems, while highlighting partnership models that can...
Peptide therapies have moved from niche compounding to mainstream outpatient care, driven by telehealth platforms and rapid market growth. This expansion has attracted regulatory attention, with state boards and courts increasingly referencing USP and as compliance benchmarks. Non‑sterile peptide...
In February 2026 the FDA approved a suite of targeted therapies, including the HER2‑mutant NSCLC kinase inhibitor zognertinib and the first all‑oral acalabrutinib‑venetoclax combo for CLL/SLL, as well as a BRAF‑targeted encorafenib regimen for metastatic colorectal cancer. A portable tumor‑treating‑fields...
The 2026 Future Leaders Awards are opening their early‑bird entry window, offering a $100 discount for nominations submitted by March 13, 2026. The program highlights high‑performing employees under 40 who are reshaping home health and related care sectors. Winners receive dual press...
March marks Multiple Myeloma Awareness Month, spotlighting a disease that affects over 85,000 new patients and 330,000 existing cases across eight major markets in 2026. GlobalData projects MM drug sales to rise from $25.5 bn in 2026 to $29.9 bn by 2032,...
Elona Toska presented a life‑course analysis of HIV risk among adolescent mothers, highlighting heightened biological susceptibility during pregnancy and breastfeeding and the structural drivers of rapid‑repeat pregnancies. While prevention of mother‑to‑child transmission programs have increased ART initiation, adherence drops postpartum,...
Mumps cases have resurfaced in the United States, with at least 34 infections confirmed across 11 states and Maryland alone reporting 26 cases. The outbreak follows a decline in childhood MMR vaccination rates that accelerated after the COVID‑19 pandemic. While...
Arbital Health announced rapid market adoption of its Merlin AI actuarial assistant, launched in October 2025. Leading payers and providers such as Arkos Health and CommuniCare have integrated the platform to monitor value‑based care contracts, forecast financial impact, and identify...
A scoping review examined literature linking Medicare Part D medication therapy management (MTM) services to health outcomes to inform a potential new quality measure. From 424 screened articles, only 27 met inclusion criteria, and GRADE assessment found high risk of bias,...
Canada’s Public Health Agency has signed a new agreement with CSL Seqirus to provide millions of doses of adjuvanted cell‑based influenza vaccine in the event of a WHO‑declared pandemic. The contract replaces a previous egg‑based arrangement and builds on the...
An updated FDA registry shows cardiology now hosts more than 200 cleared AI algorithms, including 140 directly listed under the specialty and an additional 63 imaging‑focused tools. The total number of FDA‑cleared clinical AI applications reached 1,451, with radiology still...
Philips received FDA clearance for SmartHeart, an AI‑driven planning solution that automates cardiac magnetic resonance (CMR) exam setup in under 30 seconds. The system configures 14 standard views, reduces patient breath‑holds by up to 75%, and embeds motion‑correction (Cardiac MoCo)...
QT Imaging announced that Dr. Mary W. Yamashita, a leading breast imaging specialist, will serve as its medical advisor. In this capacity she will shape clinical interpretation standards, structured reporting frameworks, training architecture, and reader‑study design. Yamashita brings decades of...
The FDA staged a media call where an anonymous senior official publicly criticized UniQure’s experimental Huntington’s disease gene therapy. The official, identified only as a practicing hematology‑oncology professor, framed his comments as serving the public interest while hinting at personal...
New York State’s Office of Mental Health launched a hybrid semantic‑interoperability framework that leverages HL7 FHIR, SNOMED CT, ICD‑10 and the Gravity Project to unify data across 22 critical‑time‑intervention (CTI) teams. The solution reconciled six to seven disparate EMR sources, converting...
Nabta Health, a Dubai‑based startup, is scaling a women‑first preventive‑care platform across the UAE and the wider Middle East‑Africa region. The hybrid model combines a licensed physical clinic, a virtual network of clinicians and AI‑driven risk assessment, and a B2B...
Zimmer Biomet presented claims‑based outcomes for its Persona IQ smart knee implant and MyMobility platform at the AAOS meeting. The analysis of 1,081 patients versus 4,324 controls showed a revision rate of 0.3% compared with 1% and a periprosthetic infection rate...
At AAAAI 2026, Novartis presented data confirming remibrutinib’s rapid and sustained efficacy in chronic spontaneous urticaria, with a 25 mg BID dose delivering significant UAS7 reductions. Phase 2 trials also demonstrated the BTK inhibitor’s potential in peanut allergy, achieving 86.7% tolerance at...
South Shore Health has installed an AI‑enabled MRI scanner that accelerates scan times and delivers higher‑resolution images for physicians. The system leverages machine‑learning reconstruction to cut patient throughput by up to 30 percent while enhancing diagnostic confidence. CIO Dr. Sam...
Cognito Therapeutics secured $105 million in Series C financing to advance its Spectris device, a non‑invasive light and sound system targeting Alzheimer’s disease. Early trials showed modest cognitive benefits despite no amyloid reduction, prompting a larger pivotal study with about...
Optum Real has teamed with Microsoft to accelerate claims and reimbursement using Azure, Dragon Copilot and Microsoft Foundry. The joint solution embeds AI‑driven coverage predictions, documentation assistance and prior‑authorization support into Optum Real’s real‑time platform. Pilot data show up to...
The FDA’s Drug Shortages portal aggregates letters, temporary import authorizations, and annual reports that detail current and historic medication scarcities. Recent communications include temporary import permits for Lederle Leucovorin, Tafenoquine, and Physostigmine to bridge supply gaps. The site also hosts...
Liberty Home Care & Hospice announced it will acquire ECU Health’s home‑based care division, encompassing four home health offices, three hospice locations and a hospice house in eastern North Carolina. Financial terms remain undisclosed, and the transaction awaits approval from...
A study published in General Psychiatry used structural MRI and machine‑learning clustering to reveal two distinct neuroanatomical subtypes of ADHD in 135 children and adolescents. Subtype A is characterized by increased gray‑matter volume in frontal regions and the cerebellum and is...
Chief medical adviser Prof Chris Whitty warned that GLP‑1 weight‑loss drugs, while effective, cannot alone resolve the UK’s escalating obesity crisis. He highlighted side‑effects such as gastrointestinal issues, rare pancreatitis, and the tendency for weight to rebound after treatment stops....
The pharmaceutical supply chain is a globally dispersed network dominated by China and India, where most active pharmaceutical ingredients (APIs) are produced. Stringent regulations such as the FDA’s Drug Supply Chain Security Act (DSCSA) demand full batch traceability, limiting rapid...
Mount Sinai, the ARC Innovation Center, and Nvidia have announced a joint effort to develop AI models capable of decoding the human genome. Leveraging Nvidia’s GPU platforms and large‑scale machine‑learning frameworks, the partnership will create tools that translate raw DNA...
OpenAI and Anthropic are rolling out both enterprise‑grade AI suites for hospitals and consumer‑focused health assistants like ChatGPT Health and Claude Pro. Enterprise tools operate under HIPAA, allowing covered entities to negotiate Business Associate Agreements that impose strict data safeguards....
U.S. hospitals are grappling with staffing shortages, rising patient volumes, and a proliferation of AI pilots that never scale. At HIMSS 2026, Taiwan’s Excellence Pavilion showcased a suite of deployment‑ready, interoperable AI solutions designed to integrate instantly into clinical workflows....
The U.S. Centers for Medicare & Medicaid Services has proposed a new advance care planning (ACP) quality measure, MUC202-020, that would tie reimbursement to documented end‑of‑life conversations for patients 18 and older. The measure would apply to hospitals, home health...
Vibe coding, introduced by Andrej Karpathy in early 2025, replaces traditional syntax‑heavy programming with natural‑language driven AI agents that can generate, debug, and deploy healthcare applications. The approach empowers clinicians to act as developers, dramatically lowering the cost and time...
The article outlines the legal requirement that U.S. wholesale drug distributors and third‑party logistics providers (3PLs) must hold a valid state license to handle prescription medications. It warns that unlicensed or unauthorized partners can expose patients to counterfeit, stolen, or...
The American Hospital Association (AHA) is coordinating with the FBI and other federal agencies to monitor cyber threats amid heightened geopolitical tensions, including the Iran conflict. While no specific threats to U.S. health care have been confirmed, the AHA urges...
Elation Health has introduced an AI‑driven billing engine that creates a touchless fast lane for primary‑care claims. The system pulls context from the Elation EHR—pre‑visit data, AI‑drafted notes, problem lists and medications—to suggest complete diagnosis, procedure and drug codes before...
Johnson & Johnson’s Tecvayli and Darzalex combination received FDA approval for second‑line multiple myeloma treatment, marking the third drug cleared under the Commissioner’s National Priority Voucher (CNPV) program. The decision was rendered in just 55 days after J&J’s filing, thanks...
Meritus Health launched the Go for Bold campaign in 2020, aiming to shed 1 million lb across Washington County, Maryland by 2030. By December 2024 the initiative recorded more than 160,000 lb lost among 7,700 participants, supported by 55 community partners. The program’s three‑pillared...
Mayo Clinic Platform Accelerate has announced a new 30‑week cohort of 18 digital‑health startups from across the globe. Participants will receive mentorship from Mayo clinicians and, crucially, access to millions of de‑identified longitudinal clinical records to train and validate AI models....
The FDA has issued a draft Level 1 guidance (Docket FDA‑2025‑D‑1504) titled “Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection.” The document targets both foreign and domestic manufacturers of human and animal drugs regulated by CDER,...
Emerging studies reveal that motherhood and menopause can act as neuroprotective milestones, strengthening women’s cognitive reserve and even thickening grey‑matter regions linked to memory. Researchers at Monash University found older mothers exhibit younger brain‑activity patterns, while Dr. Lisa Mosconi reports...
The March 3, 2026 AJMC/MHE webinar examined the Trump administration’s Great Healthcare Plan, focusing on most‑favored‑nation (MFN) drug pricing, the lapse of ACA marketplace subsidies, and the Inflation Reduction Act’s (IRA) impact on community oncology. Sixteen manufacturers have voluntarily adopted MFN pricing,...
Three biopharma firms—Bavarian Nordic, Sarepta Therapeutics, and Alkermes—announced the departures of long‑standing CEOs, prompting short‑term share declines. Bavarian Nordic’s Paul Chaplin steps down after a blocked $3 billion buyout, while Sarepta’s Doug Ingram leaves amid family health issues and recent product...
Immuneering Corporation announced its 2025 financial results, highlighting a 64% overall survival rate at 12 months for atebimetinib plus modified gemcitabine/nab‑paclitaxel in first‑line pancreatic cancer. The company secured FDA and EMA alignment on the design of its pivotal Phase 3 MAPKeeper 301...
